Variations in plasma free radicals with topical Aescin + essential phospholipids gel in venous hypertension: New clinical data

Angiology

Volumn 55, Issue SUPPL. 1, 2004, Pages

  Ricci, A ^a   Ruffini, I ^a   Cesarone, M R ^a   Cornelli, U ^a   Corsi, M ^a   Belcaro, Gianni ^a,b   Ippolito, E ^a   Dugall, M ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AESCIN PLUS ESSENTIAL PHOSPHOLIPID; ESCIN; FREE RADICAL; PHOSPHOLIPID; UNCLASSIFIED DRUG;

ADULT; AGED; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DATA ANALYSIS; DRUG EFFECT; DRUG EFFICACY; FEMALE; GEL; HUMAN; HYPERTENSION; MALE; MASSAGE; MICROANGIOPATHY; MICROCIRCULATION; NON INVASIVE MEASUREMENT; SKIN BLOOD FLOW; SKIN PROTECTION; TREATMENT INDICATION; VEIN DISEASE; VENOUS HYPERTENSION; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL EVALUATION; DIABETES MELLITUS; EVOLUTION; FREE RADICAL SCAVENGING ASSAY; MIDDLE AGED; VARICOSIS; VENOUS PRESSURE;

EID: 2442576788     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970405500603     Document Type: Conference Paper

References (4)

1. Cesarone MR, Belcaro G, Carratelli M, et al: A simple test to monitor oxidative stress. Int Angiol 18:127-130, 1999.
2. Cesarone MR, Incandela L, DeSanctis MT, et al: Variations in plasma free radicals in patients with venous hypertension with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): A clinical, prospective, placebo-controlled, randomized trial. J Cardiovasc Pharmacol Ther 7:S25-S28, 2002.
3. Incandela L, Belcaro G, Cesarone MR, et al: Oxygen-free radical decrease in hypertensive patients treated with lercanidipine. Int Angiol 20:136-140, 2001.
4. 2. A prospective-randomized-controlled study. Angiology 54:325-330, 2003.